Interventional Cardiology Clinical Features, Management, and Prognosis of Spontaneous Coronary Artery Dissection

Summary No Yes P-value ASA, n 8 64 Recurrent SCAD, n (K-M%) 0.84 . 5 years 1 (14%) 8 (17%) . 7 years 1 (14%) 10 (24%) . 10 years 1 (14%) 11 (28%) ACE/ARB, n 38 34 Recurrent SCAD, n (K-M%) 0.90 . 5 years 5 (17%) 4 (15%) . 7 years 6 (22%) 5 (26%) . 10 years 7 (27%) 5 (26%) Beta blocker, n 16 56 Recurrent SCAD, n (K-M%) 0.43 . 5 years 3 (26%) 6 (13%) . 7 years 4 (41%) 7 (17%) . 10 years 4 (41%) 8 (23%) Warfarin, n 60 12 Recurrent SCAD, n (K-M%) 0.24 . 5 years 8 (19%) 1 (9%) . 7 years 10 (27%) 1 (9%) . 10 years 11 (32%) 1 (9%) Thienopyridine, n 28 44 Recurrent SCAD, n (K-M%) 0.32 . 5 years 3 (13%) 6 (19%) . 7 years 4 (19%) 7 (27%) . 10 years 5 (25%) 7 (27%) Statin, n 28 44 Recurrent SCAD, n (K-M%) 0.022 . 5 years 2 (8%) 7 (25%) . 7 years 2 (8%) 9 (41%) . 10 years 2 (8%) 10 (50%) Fibrinolytic, n 74 13 Recurrent SCAD, n (K-M%) 0.55 . 5 years 9 (16%) 1 (8%) . 7 years 11 (23%) 2 (21%) Downloaded from http://circ.ahajournals.org/ at Mayo Clinic Libraries on July 30, 2012